New Media Consolidation In China’s Health Care Industry
This article was originally published in PharmAsia News
After undergoing market consolidation, China's health care new media industry is heading toward a monopoly. According to a survey conducted early this year by Sinomonitor International and CTR Market Research, the hospital penetration rate of China Health Media hit 79.3 percent, followed by Health Media (Huli) with 36 percent and Kangshi Media with 11 percent. The figures were compiled based on the LCD screen installation rate of 466 hospitals located in Beijing, Shanghai, Guangzhou and Shenzhen. An industry analyst observes that competitors, especially new entrants, will find it hard to challenge the dominant position of China Health Media due to its key selling points of branding and size. (Click here for more - Chinese Language)
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.